ImmunoPrecise Antibodies Ltd. (HYFT) — Cash Flow Reinvestment Rate

Latest as of October 2020: 1.62x

ImmunoPrecise Antibodies Ltd. (HYFT) has a Cash Flow Reinvestment Rate of 1.62x as of October 2020, reinvesting $715.21K (capex $715.21K ) from operating cash flow of $440.23K. Check ImmunoPrecise Antibodies Ltd. cash earnings quality to evaluate the quality of earnings relative to operating cash generation.

Reinvestment Rate

1.62x

(Capex + Investments) / Operating CF

Total Reinvested

$715.21K

Capex + Investments

Operating Cash Flow

$440.23K

USD

Capital Expenditures

$715.21K

USD

ImmunoPrecise Antibodies Ltd. Cash Flow Reinvestment Rate (2016–2016)

Historical reinvestment intensity for ImmunoPrecise Antibodies Ltd. across 1 annual periods. Explore ImmunoPrecise Antibodies Ltd. strategic investment ratio to see how much of total assets are deployed in long-term investments.

Annual Cash Flow Reinvestment Rate for ImmunoPrecise Antibodies Ltd. (2016–2016)

Year-by-year capital reinvestment analysis for ImmunoPrecise Antibodies Ltd.. For live market cap and broader valuation context, see ImmunoPrecise Antibodies Ltd. (HYFT) total market value.

Year	Reinvestment Rate	Total Reinvested (USD)	Operating CF	Capex	YoY Change
2016	0.06x	$17.48K	$284.09K	$17.48K	—

Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow